The European Commission has made two legislative proposals to amend the founding regulations of the European Medicines Agency (EMA) and the European Banking Authority (EBA). The amendments are needed in order to legally regulate the relocation of the two London-based agencies in Amsterdam and Paris respectively, after the 27 Member States’ agreement from last week. The Commission acts swiftly to ensure legal certainty and clarity by ensuring the smooth and uninterrupted functioning of EMA and EBA after March 2019.
In line with the ordinary legislative procedure, the European Parliament and the Council are expected to consider these legislative proposals as a matter of priority. They are strictly limited to the confirmation of the new headquarters of agencies under the two founding regulations.
The relocation of the two agencies is a direct consequence of the UK’s decision to leave the European Union from March 2017. The decision for relocation had to be taken by the governments of the 27 Member States. It is not a part of the negotiations on the UK’s exit from the EU.
For more information
Decision on the procedure of relocating EU agencies currently based in the UK (including criteria)
